David Mehalick - CEO and President, Director, 10%+ Owner at Coeptis Therapeutics Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO and President, Director, 10%+ Owner
Stock Symbol
COEP, COEPW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

David Mehalick - trading volume in the past year for Coeptis Therapeutics Holdings, Inc.

Holdings reported by David Mehalick for Coeptis Therapeutics Holdings, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2.78M $1.61M $0.58 Jan 8, 2024 Direct
Non-qualified Stock Options (right to buy) 375K Jan 27, 2023 Direct Common Stock
Incentive Stock Options (right to buy) 250K Jan 27, 2023 Direct Common Stock

Transactions reported by David Mehalick for Coeptis Therapeutics Holdings, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.